by Eric Umansky and Vernal Coleman

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published.

Earlier this year, doctors at Veterans Affairs hospitals in Pennsylvania sounded an alarm. Sweeping cuts imposed by the Trump administration, they told higher-ups in an email, were causing “severe and immediate impacts,” including to “life-saving cancer trials.”

The email said more than 1,000 veterans would lose access to treatment for diseases ranging from metastatic head and neck cancers, to kidney disease, to traumatic brain injuries.

“Enrollment in clinical trials is stopping,” the email warned, “meaning veterans lose access to therapies.”

The administration reversed some of its decisions, allowing some trials to continue for now. Still, other research, including the trials for treating head and neck cancer, has been stalled.

President Donald Trump has long promised to prioritize veterans.

“We love our veterans,” he said in February. “We are going to take good care of them.”

After the Department of Veterans Affairs began shedding employees and contracts, Trump’s pick to run the agency, Secretary Doug Collins, pledged, “Veterans are going to notice a change for the better.”

But dozens of internal emails obtained by ProPublica reveal a far different reality. Doctors and others at VA hospitals and clinics across the country have been sending often desperate messages to headquarters detailing how cuts will harm veterans’ care. The VA provides health care to roughly 9 million veterans.

In March, VA officials across the country warned that a critical resource — databases for tracking cancer — would no longer be kept up to date. As officials in the Pacific Northwest explained, the Department of Government Efficiency was moving to kill its contract with the outside company that maintained and ran its cancer registry, where information on the treatment of patients is collected and analyzed. DOGE had marked it for “immediate termination.”

© ProPublica